Wide Inter-institutional Variation in Performance of a Molecular Classifier for Indeterminate Thyroid Nodules

Evidence for overestimation of the prevalence of malignancy in indeterminate thyroid nodules classified as Bethesda category III

(2015) Mazen E. Iskandar et al.   SURGERY

Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay

(2014) Yuri E. Nikiforov et al.   CANCER

Implications of a suspicious afirma test result in thyroid fine-needle aspiration cytology: An institutional experience

(2014) Ricardo R. Lastra et al.   CANCER CYTOPATHOLOGY

An Independent Study of a Gene Expression Classifier (Afirma) in the Evaluation of Cytologically Indeterminate Thyroid Nodules

(2014) Bryan McIver et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Surgical Utility of Afirma: Effects of High Cancer Prevalence and Oncocytic Cell Types in Patients with Indeterminate Thyroid Cytology

(2013) R. Harrell et al.   Endocrine Practice

Multicenter Clinical Experience With the Afirma Gene Expression Classifier

(2013) Erik K. Alexander et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Evaluation of the thyroid nodule

(2013) Bryan McIver   ORAL ONCOLOGY

Malignancy Rate in Thyroid Nodules Classified as Bethesda Category III (AUS/FLUS)

(2013) Allen S. Ho et al.   THYROID

Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology

(2012) Erik K. Alexander et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impact of Mutational Testing on the Diagnosis and Management of Patients with Cytologically Indeterminate Thyroid Nodules: A Prospective Analysis of 1056 FNA Samples

(2011) Yuri E. Nikiforov et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Bethesda System for Reporting Thyroid Cytopathology

(2009) Edmund S. Cibas et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

The Bethesda System for Reporting Thyroid Cytopathology

(2009) Edmund S. Cibas et al.   THYROID